Panbela Therapeutics Inc.

OTC: PBLA
Share price (12/23/24): $0.34
Market cap (12/23/24): $1.672 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 137 pages Agreement and Plan of Merger by and Among Panbela Therapeutics, Inc., Canary Merger Holdings, Inc., Canary Merger Subsidiary I, Inc., Canary Merger Subsidiary II, Inc., Cancer Prevention Pharmaceuticals, Inc. and Fortis Advisors LLC, as Stockholder Representative Dated as of February 21, 2022

from 8-K 137 pages Agreement and Plan of Merger by and Among Panbela Therapeutics, Inc., Canary Merger Holdings, Inc., Canary Merger Subsidiary I, Inc., Canary Merger Subsidiary II, Inc., Cancer Prevention Pharmaceuticals, Inc. and Fortis Advisors LLC, as Stockholder Representative Dated as of February 21, 2022

from 10-Q 5 pages Agreement and Plan of Merger

from 8-K 4 pages Amendment No. 1 to Agreement and Plan of Merger

from 8-K 155 pages Agreement and Plan of Merger by and Among Cimarron Medical, Inc., Sun Biopharma, Inc., and Sb Acquisition Corporation